Home monitoring of asthmatic children with connected sensors

Willard, N. P.; Brinker, Bert den; Dekker, Marian K.J.; Massari, Daniele De; Klee, M.; Lint, Fik Van

doi:10.1183/13993003.congress-2018.pa4600

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Emfit QS+ACTIVE is a commercially available contactless sleep monitor that can provide a detailed description of sleep quality using ballistography [9]. The sensor is installed under the mattress to monitor activity, heart rate, and respiration rate at night and has been validated and previously used for sleep studies in both adults and children [44][45][46]. The device is CE marked and will be used for its intended use.…”

Section: Remote Monitoring Devicesmentioning

confidence: 99%

Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial

Kamp¹,

Hengeveld²,

Willard³

et al. 2023

JMIR Res Protoc

Self Cite

View full text Add to dashboard Cite

Background Childhood asthma is imposing a great financial burden on the pediatric health care system. Asthma costs are directly related to the level of asthma control. A substantial part of these costs may be preventable by the timely and adequate assessment of asthma deterioration in daily life and proper asthma management. The use of eHealth technology may assist such timely and targeted medical anticipation. Objective This paper describes the Ambulatory Pediatric Asthma Care (ALPACA) study protocol to investigate the effectiveness of an eHealth intervention consisting of remote patient monitoring and teleconsultation integrated into the daily clinical care of pediatric patients with asthma. This intervention aims to reduce health care utilization and costs and improve health outcomes compared to a control group that receives standard care. In addition, this study aims to improve future eHealth pediatric asthma care by gaining insights from home-monitoring data. Methods This study is a prospective randomized controlled effectiveness trial. A total of 40 participants will be randomized to either 3 months of eHealth care (intervention group) or standard care (control group). The eHealth intervention consists of remote patient monitoring (spirometry, pulse oximetry, electronic medication adherence tracking, and asthma control questionnaire) and web-based teleconsultation (video sharing, messages). All participants will have a 3-month follow-up with standard care to evaluate whether the possible effects of eHealth care are longer lasting. During the entire study and follow-up period, all participants will use blinded observational home monitoring (sleep, cough/wheeze sounds, air quality in bedroom) as well. Results This study was approved by the Medical Research Ethics Committees United. Enrollment began in February 2023, and the results of this study are expected to be submitted for publication in July 2024. Conclusions This study will contribute to the existing knowledge on the effectiveness of eHealth interventions that combine remote patient monitoring and teleconsultation for health care utilization, costs, and health outcomes. Furthermore, the observational home-monitoring data can contribute to improved identification of early signs of asthma deterioration in pediatric patients. Researchers and technology developers could use this study to guide and improve eHealth development, while health care professionals, health care institutions, and policy makers may employ our results to make informed decisions to steer toward high-quality, efficient pediatric asthma care. Trial Registration ClinicalTrials.gov NCT05517096; https://clinicaltrials.gov/ct2/show/NCT05517096 International Registered Report Identifier (IRRID) PRR1-10.2196/45585

show abstract

Section: Remote Monitoring Devicesmentioning

confidence: 99%

Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial

Kamp¹,

Hengeveld²,

Willard³

et al. 2023

JMIR Res Protoc

Self Cite

View full text Add to dashboard Cite

show abstract

Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial (Preprint)

Kamp¹,

Hengeveld²,

Willard³

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

BACKGROUND Childhood asthma is imposing a great financial burden on the pediatric health care system. Asthma costs are directly related to the level of asthma control. A substantial part of these costs may be preventable by timely and adequate assessment of asthma deterioration in daily life and proper asthma management. The use of eHealth technology may assist such timely and targeted medical anticipation. OBJECTIVE This paper describes the ALPACA study protocol, to investigate the effectiveness of an eHealth intervention consisting of remote patient monitoring and teleconsultation integrated in daily clinical care of pediatric asthma patients. This intervention aims to reduce health care utilization and costs and improve health outcomes compared to a control group that receives standard care. In addition, this study aims to improve future eHealth pediatric asthma care by gaining insights from home-monitoring data. METHODS This study is a prospective randomized controlled trial. Forty subjects will be randomized to either three months of eHealth care (intervention group) or standard care (control group). The eHealth intervention consists of remote patient monitoring (spirometry, pulse oximetry, electronic medication adherence tracking and asthma control questionnaire) and web-based teleconsultation (video sharing, messages). All subjects have a three-month follow up with standard care to evaluate whether possible effects of eHealth care are longer lasting. During the entire study and follow-up period, all subjects use blinded observational home-monitoring (sleep, cough/wheeze sounds, air quality in bedroom) as well. RESULTS The study was approved by medical ethical committee, enrolment will start in 2023 and results of the study are expected to be submitted for publication in June 2024. CONCLUSIONS This study will contribute to the existing knowledge on the effectiveness of eHealth interventions that combine remote patient monitoring and teleconsultation on health care utilization, costs and health outcomes. Furthermore, the observational home-monitoring data can contribute to improved identification of early signs of asthma deterioration in pediatric patients. Researchers and technology developers could use this study to guide and improve eHealth development, while health care professionals, health care institutions and policymakers may employ our results to make informed decisions to steer towards high-quality, efficient pediatric asthma care. CLINICALTRIAL ClinicalTrials.gov Identifier: NCT05517096

show abstract

Home monitoring of asthmatic children with connected sensors

Cited by 2 publications

References 0 publications

Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial

Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial

Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial (Preprint)

Contact Info

Product

Resources

About